A Phase I Trial of SIM1811-03 in Subjects With Advanced Solid Tumors and Cutaneous T-cell Lymphoma

Clinical trial NCT05569057 · UNKNOWN

Trial details

NCT number: NCT05569057
Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor Cutaneous T-cell Lymphoma (CTCL)

Start date: 2022-09-30
Primary completion: 2024-06-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.